Reaction Details |
| Report a problem with these data |
Target | Cyclin-dependent kinase 5 |
---|
Ligand | BDBM50435028 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_964508 (CHEMBL2393653) |
---|
IC50 | >100000±n/a nM |
---|
Citation | Lo Monte, F; Kramer, T; Gu, J; Brodrecht, M; Pilakowski, J; Fuertes, A; Dominguez, JM; Plotkin, B; Eldar-Finkelman, H; Schmidt, B Structure-based optimization of oxadiazole-based GSK-3 inhibitors. Eur J Med Chem61:26-40 (2013) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Cyclin-dependent kinase 5 |
---|
Name: | Cyclin-dependent kinase 5 |
Synonyms: | CDK5 | CDK5_HUMAN | CDKN5 | Cell division protein kinase 5 | Cyclin-dependent kinase 5 (CDK5/ p25) | Cyclin-dependent kinase 5 (CDK5/p35) | Cyclin-dependent-like kinase 5 | Cyclin-dependent-like kinase 5 (CDK5) | PSSALRE | Serine/threonine-protein kinase PSSALRE | Tau protein kinase II catalytic subunit |
Type: | Enzyme Subunit |
Mol. Mass.: | 33308.61 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 292 |
Sequence: | MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH
KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR
NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS
TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP
MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP
|
|
|
BDBM50435028 |
---|
n/a |
---|
Name | BDBM50435028 |
Synonyms: | CHEMBL2391098 |
Type | Small organic molecule |
Emp. Form. | C21H13FN4OS |
Mol. Mass. | 388.418 |
SMILES | Fc1ccc(-c2ccc(CSc3nnc(o3)-c3ccncc3)cc2)c(c1)C#N |
Structure |
|